Who invested in Aerpio Therapeutics?
Aerpio Therapeutics's investors include Kearny Venture Partners, Triathlon Medical Venture Partners, Novartis Venture Fund, Venture Investors and Athenian Venture Partners, and 4 more on record.
United States · Venture startup
4 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$63Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $22M sold, first sale Apr 2014
Reported by finsmes.comSEC filing: $27M sold, first sale Aug 2012
Reported by finsmes.comSEC filing: $10M sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Dec 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Aerpio Therapeutics's investors include Kearny Venture Partners, Triathlon Medical Venture Partners, Novartis Venture Fund, Venture Investors and Athenian Venture Partners, and 4 more on record.
Aerpio Therapeutics has raised $63M across 4 rounds since 2012.
Aerpio Therapeutics's most recent round was a Venture of $22M in Apr 2014.
Aerpio Therapeutics's largest round on record is $27M (Series A), in Aug 2012.
Aerpio Therapeutics's first round on record, in Aug 2012, was backed by Novartis Venture Fund, Venture Investors and Kearny Venture Partners and 4 others.
Aerpio Therapeutics's latest named round is a Venture, in Apr 2014.
Aerpio Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.